Success Metrics

Clinical Success Rate
92.3%

Based on 12 completed trials

Completion Rate
92%(12/13)
Active Trials
3(14%)
Results Posted
17%(2 trials)
Terminated
1(5%)

Phase Distribution

Ph phase_2
4
18%
Ph phase_3
4
18%
Ph phase_1
2
9%
Ph phase_4
4
18%
Ph early_phase_1
2
9%
Ph not_applicable
5
23%

Phase Distribution

4

Early Stage

4

Mid Stage

8

Late Stage

Phase Distribution21 total trials
Early Phase 1First-in-human
2(9.5%)
Phase 1Safety & dosage
2(9.5%)
Phase 2Efficacy & side effects
4(19.0%)
Phase 3Large-scale testing
4(19.0%)
Phase 4Post-market surveillance
4(19.0%)
N/ANon-phased studies
5(23.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

12 of 14 finished

Non-Completion Rate

14.3%

2 ended early

Currently Active

3

trials recruiting

Total Trials

22

all time

Status Distribution
Active(3)
Completed(12)
Terminated(2)
Other(5)

Detailed Status

Completed12
unknown5
Recruiting3
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
22
Active
3
Success Rate
92.3%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (9.5%)
Phase 12 (9.5%)
Phase 24 (19.0%)
Phase 34 (19.0%)
Phase 44 (19.0%)
N/A5 (23.8%)

Trials by Status

completed1255%
recruiting314%
withdrawn15%
unknown523%
terminated15%

Recent Activity

Clinical Trials (22)

Showing 20 of 22 trialsScroll for more
NCT07185230Not Applicable

Atosiban in Women With Previous Implantation Failure and Abnormal Uterine Contractions

Recruiting
NCT07140237Early Phase 1

The Effect of Oral Oxytocin and Atosiban on Top-down Attention ( OTAtosiban )

Recruiting
NCT07093060Early Phase 1

The Effect of Oral Oxytocin and Atosiban on Social Attention

Recruiting
NCT06537778Not Applicable

Perioperative Use of Atosiban for Ultrasound-indicated Cerclage to Reduce Spontaneous Preterm Birth(sPTB)

Completed
NCT05693688Phase 4

Atosiban Versus Placebo in the Treatment of Late Threatened Pre-term Birth

Completed
NCT04468568

In Utero Repair of Myelomeningocele: Atosiban Versus Terbutaline

Completed
NCT05382143Phase 2

The Effect of Selective Oxytocin Receptor Inhibitors on Endometriosis-related Pain

Unknown
NCT03369262Phase 2

PoC Study of OBE022 in Threatened Preterm Labour

Unknown
NCT01673399Phase 4

Oxytocin Antagonist in Patients With Repeated Failure of Implantation

Completed
NCT03904745Not Applicable

Effect of Oxytocin Antagonists on Implantation Success Rates of Frozen-thawed Embryo Transfer

Unknown
NCT02292771Phase 3

A Randomized Study Comparing the Efficacy and Safety of Retosiban Versus Atosiban for Women in Spontaneous Preterm Labour

Terminated
NCT02292784Phase 3

Follow up Study to Assess Long Term Safety and Outcomes in Infants and Children Born to Mothers Participating in Retosiban Treatment Studies

Completed
NCT03570294Not Applicable

Oxidative Stress in Women Treated With Atosiban for Impending Preterm Birth

Completed
NCT00587327Phase 2

Effect of Oxytocin and Vasopressin Antagonists on Uterine Contractions

Completed
NCT02893722Phase 1

A Randomized Double Blind Comparison of Atosiban in Patients With RIF Undergoing IVF Treatment

Unknown
NCT02725736Phase 3

Tocolytic Therapy for Preterm Labor in Multiple Gestation

Unknown
NCT01314859Phase 3

Nifedipine Treatment in Preterm Labor

Withdrawn
NCT01501214Phase 4

Use of Atosiban in in Vitro Fertilization (IVF) Treatment

Completed
NCT00599898Phase 4

Nifedipine Compared to Atosiban for Treating Preterm Labor

Completed
NCT01493440Not Applicable

Atosiban Improves Implantation and Pregnancy Rates in Patients With Repeated Implantation Failure

Completed

Drug Details

Intervention Type
DRUG
Total Trials
22